CRWV

CoreWeave, Inc. Class A Common Stock

52
Fundamentals43/ 100
Valuation50/ 100
Upside potential65/ 100
Risk potential42/ 100

CRWV offers stronger modeled upside, but that advantage does not outweigh its weaker overall profile.

GS

The Goldman Sachs Group, Inc.

64
Fundamentals69/ 100
Valuation50/ 100
Upside potential57/ 100
Risk potential14/ 100

GS has the edge over CRWV overall, supported by lower modeled downside and stronger fundamentals.

CRWV Fundamentals

MetricStatus
Strong
Under pressure
Weak
Strong

CRWV's revenue and balance sheet are currently strong, but its profitability and cash flow are under pressure.

GS Fundamentals

MetricStatus
Strong
Strong
N/A
N/A

GS's revenue and profitability are currently strong. Free cash flow and net leverage aren't meaningful measures for financial services companies like GS.

CRWV PE Valuation

CRWV has no meaningful PE right now: it lost money over the past year.

GS PE Valuation

CHEAPFAIREXPENSIVE5.2x10x16x21x
CHEAPFAIREXPENSIVE5.2x10x16x21x
LevelPEPriceVs current
Cheap7.6x$528-42%
Current13x$914—
Forward13x$914—
Fair14x$940+2.9%
Expensive17x$1,214+33%

Historical ranges are pointers, not guarantees.

GS's PE is 13x, but its earnings don't support one, so it isn't a reliable read right now.

CRWV Forward outlook

MetricOutlook
--
Losses shrinking
Strong growth
Strongly improving
Moderate
Low

Analysts expect CRWV's losses to shrink, with revenue growing. However, they disagree widely on these estimates.

GS Forward outlook

MetricOutlook
Stable
Strong growth
Growth
Strongly improving
Limited
Low

Analysts expect earnings and revenue growth for GS, with profitability improving. However, they disagree widely on these estimates.

CRWV Risk to reward

ScenarioChangePrice
Upside+79%$101.48
Downside-42%$32.77

Calculated from the latest close: $56.60 on Nov 12.

CRWV has a better modeled risk to reward balance than GS, with more potential upside relative to its potential downside.

GS Risk to reward

ScenarioChangePrice
Upside+19%$1,085.26
Downside-14%$781.84

Calculated from the latest close: $913.60 on Nov 12.

GS trails CRWV on modeled risk to reward, with less potential upside relative to its potential downside.

CRWV Earnings Per Share

Q3 2024: $-2.42Q4 2024: $-2.17Q1 2025: $-3.34Q2 2025: $-3.10Q3 2025: $-2.48Q4 2025: $-2.81Q1 2026: $-2.72Q2 2026: $-3.26Q3 2026: $-4.31
Q3 2024: $-2.42Q4 2024: $-2.17Q1 2025: $-3.34Q2 2025: $-3.10Q3 2025: $-2.48Q4 2025: $-2.81Q1 2026: $-2.72Q2 2026: $-3.26Q3 2026: $-4.31
QuarterTTM EPSYoY
Q3 2026-$4.31-$1.83
Q2 2026-$3.26-$0.16
Q1 2026-$2.72+$0.62
Q4 2025-$2.81-$0.64
Q3 2025-$2.48-$0.06

CRWV lost $4.31 per share over the past year, a bigger loss than the year before.

GS Earnings Per Share

Q4 2023: $22.87Q1 2024: $25.66Q2 2024: $31.20Q3 2024: $34.13Q4 2024: $40.54Q1 2025: $43.08Q2 2025: $45.37Q3 2025: $49.22Q4 2025: $51.32Q1 2026: $54.75Q2 2026: $64.82Q3 2026: $69.58Forward: $72.35
Q4 2023: $22.87Q1 2024: $25.66Q2 2024: $31.20Q3 2024: $34.13Q4 2024: $40.54Q1 2025: $43.08Q2 2025: $45.37Q3 2025: $49.22Q4 2025: $51.32Q1 2026: $54.75Q2 2026: $64.82Q3 2026: $69.58Forward: $72.35
QuarterTTM EPSYoY
Forward$72.35+4%
Q3 2026$69.58+41%
Q2 2026$64.82+43%
Q1 2026$54.75+27%
Q4 2025$51.32+27%
Q3 2025$49.22+44%
Q2 2025$45.37+45%
Q1 2025$43.08+68%
Q4 2024$40.54+77%

GS has the edge over CRWV on earnings quality, reporting a profit while its opponent remains loss making.

CRWV Quarterly Revenue

Q4 2023: $116MQ1 2024: $189MQ2 2024: $395MQ3 2024: $584MQ4 2024: $747MQ1 2025: $982MQ2 2025: $1.2BQ3 2025: $1.4BQ4 2025: $1.6BQ1 2026: $2.1BQ2 2026: $2.6BQ3 2026: $3.7B
Q4 2023: $116MQ1 2024: $189MQ2 2024: $395MQ3 2024: $584MQ4 2024: $747MQ1 2025: $982MQ2 2025: $1.2BQ3 2025: $1.4BQ4 2025: $1.6BQ1 2026: $2.1BQ2 2026: $2.6BQ3 2026: $3.7B
QuarterRevenueYoY
Q3 2026$3.7B+168%
Q2 2026$2.6B+112%
Q1 2026$2.1B+112%
Q4 2025$1.6B+110%
Q3 2025$1.4B+134%
Q2 2025$1.2B+207%
Q1 2025$981.6M+420%
Q4 2024$747.4M+544%

CRWV has the edge over GS on sales, with more consistent year-over-year improvement.

GS Quarterly Revenue

Q4 2023: $11.3BQ1 2024: $14.2BQ2 2024: $12.7BQ3 2024: $12.7BQ4 2024: $13.9BQ1 2025: $15.1BQ2 2025: $14.6BQ3 2025: $15.2BQ4 2025: $13.5BQ1 2026: $17.2BQ2 2026: $20.3BQ3 2026: $18.7B
Q4 2023: $11.3BQ1 2024: $14.2BQ2 2024: $12.7BQ3 2024: $12.7BQ4 2024: $13.9BQ1 2025: $15.1BQ2 2025: $14.6BQ3 2025: $15.2BQ4 2025: $13.5BQ1 2026: $17.2BQ2 2026: $20.3BQ3 2026: $18.7B
QuarterRevenueYoY
Q3 2026$18.7B+23%
Q2 2026$20.3B+39%
Q1 2026$17.2B+14%
Q4 2025$13.5B-3%
Q3 2025$15.2B+20%
Q2 2025$14.6B+15%
Q1 2025$15.1B+6%
Q4 2024$13.9B+23%

GS's revenue is growing: $18.7B last quarter, up 23% from the same quarter a year ago.

CRWV Free Cash Flow

Q4 2023: −$1.1BQ1 2024: $297MQ2 2024: −$2.4BQ3 2024: −$574MQ4 2024: −$3.3BQ1 2025: −$1.3BQ2 2025: −$2.7BQ3 2025: −$700MQ4 2025: −$2.5BQ1 2026: −$4.7BQ2 2026: −$5.7BQ3 2026: −$7.5B
Q4 2023: −$1.1BQ1 2024: $297MQ2 2024: −$2.4BQ3 2024: −$574MQ4 2024: −$3.3BQ1 2025: −$1.3BQ2 2025: −$2.7BQ3 2025: −$700MQ4 2025: −$2.5BQ1 2026: −$4.7BQ2 2026: −$5.7BQ3 2026: −$7.5B
QuarterFree cash flowYoY
Q3 2026-$7.5B-$6.8B
Q2 2026-$5.7B-$3B
Q1 2026-$4.7B-$3.4B
Q4 2025-$2.5B+$810.3M
Q3 2025-$699.8M-$125.8M
Q2 2025-$2.7B-$339.3M
Q1 2025-$1.3B-553%
Q4 2024-$3.3B-$2.2B

CRWV has burned cash in almost every quarter: −$20.4B over the past year, against −$8.1B the year before.

GS Free Cash Flow

Q4 2023: −$28.9BQ1 2024: −$28.5BQ2 2024: $5.6BQ3 2024: −$38.5BQ4 2024: $46.2BQ1 2025: −$37.7BQ2 2025: $5.2BQ3 2025: $2.1BQ4 2025: −$16.8BQ1 2026: −$32.4BQ2 2026: $5.6BQ3 2026: $3.7B
Q4 2023: −$28.9BQ1 2024: −$28.5BQ2 2024: $5.6BQ3 2024: −$38.5BQ4 2024: $46.2BQ1 2025: −$37.7BQ2 2025: $5.2BQ3 2025: $2.1BQ4 2025: −$16.8BQ1 2026: −$32.4BQ2 2026: $5.6BQ3 2026: $3.7B
QuarterFree cash flowYoY
Q3 2026$3.7B+72%
Q2 2026$5.6B+7.8%
Q1 2026-$32.4B+$5.3B
Q4 2025-$16.8B-136%
Q3 2025$2.1B+$40.6B
Q2 2025$5.2B-6.8%
Q1 2025-$37.7B-$9.2B
Q4 2024$46.2B+$75.1B

GS has the edge over CRWV on cash flow, with more consistent year-over-year improvement.

CRWV Total Shares

Q4 2023: 404MQ1 2024: 404MQ2 2024: 404MQ3 2024: 214MQ4 2024: 239MQ1 2025: 249MQ2 2025: 487MQ3 2025: 498MQ4 2025: 436MQ1 2026: 527MQ2 2026: 551MQ3 2026: 559M
Q4 2023: 404MQ1 2024: 404MQ2 2024: 404MQ3 2024: 214MQ4 2024: 239MQ1 2025: 249MQ2 2025: 487MQ3 2025: 498MQ4 2025: 436MQ1 2026: 527MQ2 2026: 551MQ3 2026: 559M
PeriodChange %Net change
Quarterly+1.5%+8M shares
1 year+12%+61.1M shares

CRWV has 559M diluted shares, up 12% from a year ago.

GS Total Shares

Q4 2023: 346MQ1 2024: 340MQ2 2024: 336MQ3 2024: 331MQ4 2024: 334MQ1 2025: 325MQ2 2025: 318MQ3 2025: 315MQ4 2025: 318MQ1 2026: 308MQ2 2026: 305MQ3 2026: 301M
Q4 2023: 346MQ1 2024: 340MQ2 2024: 336MQ3 2024: 331MQ4 2024: 334MQ1 2025: 325MQ2 2025: 318MQ3 2025: 315MQ4 2025: 318MQ1 2026: 308MQ2 2026: 305MQ3 2026: 301M
PeriodChange %Net change
Quarterly-1.2%-3.8M shares
1 year-4.4%-13.9M shares
3 years-12%-42.8M shares
5 years-15%-52.8M shares
Available history-20%-74.4M shares

GS has the edge over CRWV on shareholder dilution, with a more favorable share count trend.

CRWV Net Leverage

Q4 2024: 19.3xQ1 2025: 8.4xQ2 2025: 6.5xQ3 2025: 5.6xQ4 2025: 7.6xQ1 2026: 7.6xQ2 2026: -1.5xQ3 2026: -0.8x
Q4 2024: 19.3xQ1 2025: 8.4xQ2 2025: 6.5xQ3 2025: 5.6xQ4 2025: 7.6xQ1 2026: 7.6xQ2 2026: -1.5xQ3 2026: -0.8x
QuarterNet LeverageStatus
Q3 2026-0.8xNet Cash
Q2 2026-1.5xNet Cash
Q1 20267.6xHigh
Q4 20257.6xHigh
Q3 20255.6xHigh
Q2 20256.5xHigh
Q1 20258.4xHigh
Q4 202419.3xHigh

CRWV has more cash than debt.

GS Net Leverage

Q4 2023: -9.6xQ1 2024: -6.8xQ2 2024: -6.5xQ3 2024: -3.5xQ4 2024: -4.7xQ1 2025: -3.9xQ2 2025: -3.1xQ3 2025: -3.5xQ4 2025: -6.4xQ1 2026: -6.7xQ2 2026: -6.1xQ3 2026: -5.4x
Q4 2023: -9.6xQ1 2024: -6.8xQ2 2024: -6.5xQ3 2024: -3.5xQ4 2024: -4.7xQ1 2025: -3.9xQ2 2025: -3.1xQ3 2025: -3.5xQ4 2025: -6.4xQ1 2026: -6.7xQ2 2026: -6.1xQ3 2026: -5.4x
QuarterNet LeverageStatus
Q3 2026-5.4xNet Cash
Q2 2026-6.1xNet Cash
Q1 2026-6.7xNet Cash
Q4 2025-6.4xNet Cash
Q3 2025-3.5xNet Cash
Q2 2025-3.1xNet Cash
Q1 2025-3.9xNet Cash
Q4 2024-4.7xNet Cash

GS has the edge over CRWV on leverage, with a lower net debt burden relative to earnings.

CRWV Weekly Momentum

MetricValueStatus
RSI39.7Neutral
Stochastic11.3Oversold

CRWV's weekly RSI is 40 (neutral) and its Stochastic is 11 (oversold).

GS Weekly Momentum

MetricValueStatus
RSI44.5Neutral
Stochastic16.3Oversold

GS's weekly RSI is 45 (neutral) and its Stochastic is 16 (oversold).

CRWV PE vs Technology Sector

CRWV has no meaningful PE right now: it lost money over the past year.

GS PE vs Financial Services Sector

MetricGSSector medianRelative
PE13x13x0.8% above
PE %466317 pts below

GS is trading at 13x earnings, in line with the Financial Services sector's median of 13x, though its earnings don't support one.

CRWV Weekly Moving Averages

Moving averageMA priceRelative
8 week MA$66.615% below
20 week MA$77.427% below
50 week MA$87.435% below

GS has stronger trend alignment. CRWV is above 0 of 3 weekly averages versus GS above 3 of 5.

GS Weekly Moving Averages

Moving averageMA priceRelative
8 week MA$895.52% above
20 week MA$977.46.5% below
50 week MA$945.43.4% below
100 week MA$804.514% above
200 week MA$602.752% above

GS's trend is mixed: it's above three of its five weekly moving averages, and 52% above its 200-week average.

CRWV Yearly ROI

YearStart priceEnd priceROI
2025$40.0$76.4+91%
2026 YTD$76.4$56.6-26%

CRWV has finished every year since 2025 higher, and it's down 26% so far in 2026.

GS Yearly ROI

YearStart priceEnd priceROI
2020$230.7$256.2+11%
2021$256.2$385.0+50%
2022$385.0$345.5-10%
2023$345.5$385.8+12%
2024$385.8$576.2+49%
2025$576.2$907.0+57%
2026 YTD$907.0$913.6+0.7%

GS has the edge over CRWV on returns for 2026, with the stronger performance.

Give your agent the market.

Get API key